Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer

Archives of Dermatology

Volumn 145, Issue 1, 2009, Pages 97-98

  Kawakami, Tamihiro ^a   Tsutsumi, Yuko ^b   Soma, Yoshinao ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ADULT; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SEROLOGY; SKIN BIOPSY; SYSTEMIC SCLEROSIS; TREATMENT DURATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; SCLERODERMA, LIMITED;

EID: 58849089962     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.532     Document Type: Letter

References (5)

1. Kupfer I, Balguerie X, Courville P, et al. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study. J Am Acad Dermatol. 2003;48(2):279-281.
2. Itoh M, Yanaba K, Kobayashi T, Nakagawa H. Taxane-induced scleroderma. Br J Dermatol. 2007;156(2):363-367.
3. Launay D, Le Berre R, Hatron PY, et al. Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol. 2004;23(6):516-522.
4. Alexandrescu DT, Bhagwati NS, Wiernik PH. Chemotherapy-induced scleroderma: a pleiomorphic syndrome. Clin Exp Dermatol. 2005;30(2):141-145.
5. Derk CT. Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol. 2007;26(10):1615-1619.